Sarah B Bateni1, Frederick J Meyers2, Richard J Bold1, Robert J Canter3. 1. Divison of Surgical Oncology, Department of Surgery, University of California at Davis Medical Center, Sacramento, California. 2. Division of Hematology/Oncology, Department of Internal Medicine, University of California at Davis Medical Center, Sacramento, California; Vice Dean UC Davis School of Medicine, University of California at Davis Medical Center, California. 3. Divison of Surgical Oncology, Department of Surgery, University of California at Davis Medical Center, Sacramento, California. Electronic address: robert.canter@ucdmc.ucdavis.edu.
Abstract
BACKGROUND: Surgical morbidity and mortality (M&M) for patients with disseminated malignancy (DMa) is high, and some have questioned the role of surgery. Therefore, we sought to characterize temporal trends in M&M among DMa patients, hypothesizing that surgical intervention would remain prevalent. METHODS: We queried the American College of Surgeons National Surgical Quality Improvement Program from 2006-2010. Excluding patients undergoing a primary hepatic operation, we identified 21,755 patients with DMa. Parametric and/or nonparametric statistics and logistic regression were used to evaluate temporal trends and predictors of M&M. RESULTS: The prevalence of surgical intervention for DMa declined slightly over the time period, from 1.9%-1.6% of all procedures (P < 0.01). Among DMa patients, the most frequent operations performed were bowel resection, other gastrointestinal procedures, and multivisceral resections, these all showed small statistically significant decreases over time (P < 0.01). The rate of emergency operations also decreased (P < 0.01). In contrast, the rate of preoperative independent functional status rose, whereas the rate of preoperative weight loss and sepsis decreased (P < 0.01). Rates of 30-d morbidity (33.7 versus 26.6%), serious morbidity (19.8 versus 14.2%), and mortality (10.4 versus 9.3%) all decreased over the study period (P < 0.05). Multivariate analysis identified standard predictors (e.g., impaired functional status, preoperative weight loss, preoperative sepsis, and hypoalbuminemia) of worse 30-d M&M. CONCLUSIONS: Thirty-day morbidity, serious morbidity, and mortality have decreased incrementally for patients with DMa undergoing surgical intervention, but surgical intervention remains prevalent. These data further highlight the importance of careful patient selection and goal-directed therapy in patients with incurable malignancy.
BACKGROUND: Surgical morbidity and mortality (M&M) for patients with disseminated malignancy (DMa) is high, and some have questioned the role of surgery. Therefore, we sought to characterize temporal trends in M&M among DMapatients, hypothesizing that surgical intervention would remain prevalent. METHODS: We queried the American College of Surgeons National Surgical Quality Improvement Program from 2006-2010. Excluding patients undergoing a primary hepatic operation, we identified 21,755 patients with DMa. Parametric and/or nonparametric statistics and logistic regression were used to evaluate temporal trends and predictors of M&M. RESULTS: The prevalence of surgical intervention for DMa declined slightly over the time period, from 1.9%-1.6% of all procedures (P < 0.01). Among DMapatients, the most frequent operations performed were bowel resection, other gastrointestinal procedures, and multivisceral resections, these all showed small statistically significant decreases over time (P < 0.01). The rate of emergency operations also decreased (P < 0.01). In contrast, the rate of preoperative independent functional status rose, whereas the rate of preoperative weight loss and sepsis decreased (P < 0.01). Rates of 30-d morbidity (33.7 versus 26.6%), serious morbidity (19.8 versus 14.2%), and mortality (10.4 versus 9.3%) all decreased over the study period (P < 0.05). Multivariate analysis identified standard predictors (e.g., impaired functional status, preoperative weight loss, preoperative sepsis, and hypoalbuminemia) of worse 30-d M&M. CONCLUSIONS: Thirty-day morbidity, serious morbidity, and mortality have decreased incrementally for patients with DMa undergoing surgical intervention, but surgical intervention remains prevalent. These data further highlight the importance of careful patient selection and goal-directed therapy in patients with incurable malignancy.
Authors: René Adam; Laurence Chiche; Thomas Aloia; Dominique Elias; Rémy Salmon; Michel Rivoire; Daniel Jaeck; Jean Saric; Yves Patrice Le Treut; Jacques Belghiti; Georges Mantion; Gilles Mentha Journal: Ann Surg Date: 2006-10 Impact factor: 12.969
Authors: Thomas A Aloia; Jean-Nicolas Vauthey; Evelyne M Loyer; Dario Ribero; Timothy M Pawlik; Steven H Wei; Steven A Curley; Daria Zorzi; Eddie K Abdalla Journal: Arch Surg Date: 2006-05
Authors: Laurence E McCahill; David D Smith; Tami Borneman; Gloria Juarez; Carey Cullinane; David Z J Chu; Betty R Ferrell; Lawrence D Wagman Journal: Ann Surg Oncol Date: 2003-07 Impact factor: 5.344
Authors: Sarah B Bateni; Alicia A Gingrich; Susan L Stewart; Frederick J Meyers; Richard J Bold; Robert J Canter Journal: BMC Cancer Date: 2018-11-26 Impact factor: 4.430
Authors: Sarah B Bateni; Alicia A Gingrich; Amanda R Kirane; Candice A M Sauder; Sepideh Gholami; Richard J Bold; Frederick J Meyers; Robert J Canter Journal: Ann Surg Oncol Date: 2021-04-07 Impact factor: 5.344